Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DARATUMUMAB vs DARIDOREXANT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DARATUMUMAB vs DARIDOREXANT: Safety Overview

Metric DARATUMUMAB DARIDOREXANT
Total FAERS Reports 27,387 2,016
Deaths Reported 3,941 38
Death Rate 14.4% 1.9%
Hospitalizations 10,205 77
Average Patient Age 66.8 yrs 59.4 yrs
% Female Patients 44.5% 65.1%
FDA Approval Date N/A Apr 7, 2022
Manufacturer Janssen Biotech, Inc. N/A
Route INTRAVENOUS N/A
Marketing Status Prescription Prescription